Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI

BACKGROUND: Osteogenesis imperfecta (OI) is a hereditary disease causing reduced bone mass, increased fracture rate, long bone deformities and vertebral compressions. Additional non skeletal findings are caused by impaired collagen function and include hyperlaxity of joints and blue sclera. Most OI...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hoyer-Kuhn, Heike, Netzer, Christian, Koerber, Friederike, Schoenau, Eckhard, Semler, Oliver
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4180531/
https://ncbi.nlm.nih.gov/pubmed/25257953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-014-0145-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars